Extramedullary plasmacytoma of the thyroid: report of a rare case

Abstract

et al. [1] have shown that, on pre-and post-treatment evaluation of the lymph nodes, infiltration of Ki67-and CD3-positive, CD8-positive, granzyme B-positive T cells increases.It has been observed that, in patients with Hodgkin lymphoma who are treated with lenalidomide and who develop TFR, cytokines (particularly interleukin [IL]-6, IL7, APRIL, BAFF/BLyS) are released because of B cell activation, and levels of free light chains increase distinctively; these changes are reflected in the clinical properties.Likewise, it has been shown that when the TFR subsides, cytokines and light chain levels decrease to normal levels [5].Therefore, for patients who develop TFR, it is suggested that dexamethasone be used, as it provides distinctive improvement by especially inhibiting CD40 regulation [1].The mechanism through which the R-HCVAD treatment leads to TFR is not known, but one of the above-listed mechanisms may play a role.